应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ALMS Alumis Inc.
盘前交易 07-10 07:30:32 EDT
3.50
+0.02
+0.57%
最高
3.59
最低
3.42
成交量
52.30万
今开
3.51
昨收
3.48
日振幅
4.85%
总市值
1.90亿
流通市值
3,032万
总股本
5,441万
成交额
183.37万
换手率
6.04%
流通股本
866.42万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Alumis Inc.盘中异动 早盘快速上涨5.14%
市场透视 · 07-08 13:41
Alumis Inc.盘中异动 早盘快速上涨5.14%
Alumis Inc.盘中异动 大幅上涨5.00%
市场透视 · 07-01
Alumis Inc.盘中异动 大幅上涨5.00%
Alumis Inc.盘中异动 股价大涨5.30%报3.18美元
市场透视 · 06-30
Alumis Inc.盘中异动 股价大涨5.30%报3.18美元
Alumis Inc.盘中异动 股价大涨5.12%
市场透视 · 06-26
Alumis Inc.盘中异动 股价大涨5.12%
Alumis Inc.盘中异动 早盘股价大涨5.00%报2.94美元
市场透视 · 06-24
Alumis Inc.盘中异动 早盘股价大涨5.00%报2.94美元
Alumis Inc.盘中异动 临近午盘急速下挫5.32%报2.85美元
市场透视 · 06-20
Alumis Inc.盘中异动 临近午盘急速下挫5.32%报2.85美元
Guggenheim:重申Alumis(ALMS.US)买入评级, 目标价18.00美元。
金融界 · 06-10
Guggenheim:重申Alumis(ALMS.US)买入评级, 目标价18.00美元。
Alumis Inc.盘中异动 股价大跌5.01%
市场透视 · 06-09
Alumis Inc.盘中异动 股价大跌5.01%
Alumis Inc.盘中异动 早盘快速上涨5.88%
市场透视 · 06-04
Alumis Inc.盘中异动 早盘快速上涨5.88%
Alumis Inc.盘中异动 急速跳水5.00%报3.33美元
市场透视 · 06-02
Alumis Inc.盘中异动 急速跳水5.00%报3.33美元
Alumis Inc.盘中异动 大幅下跌5.88%
市场透视 · 05-30
Alumis Inc.盘中异动 大幅下跌5.88%
Alumis Inc.盘中异动 早盘大幅跳水5.34%
市场透视 · 05-27
Alumis Inc.盘中异动 早盘大幅跳水5.34%
Alumis Inc.2025财年第一财季实现净利润-98.96百万美元,同比减少98.52%
市场透视 · 05-22
Alumis Inc.2025财年第一财季实现净利润-98.96百万美元,同比减少98.52%
Alumis Inc.盘中异动 早盘快速下挫7.95%报4.40美元
市场透视 · 05-22
Alumis Inc.盘中异动 早盘快速下挫7.95%报4.40美元
Alumis Inc.盘中异动 快速上涨5.33%报5.14美元
市场透视 · 05-21
Alumis Inc.盘中异动 快速上涨5.33%报5.14美元
Alumis Inc.盘中异动 急速下挫5.38%报5.63美元
市场透视 · 05-20
Alumis Inc.盘中异动 急速下挫5.38%报5.63美元
Alumis Inc.盘中异动 下午盘急速拉升5.03%
市场透视 · 05-19
Alumis Inc.盘中异动 下午盘急速拉升5.03%
Alumis Inc.盘中异动 股价大涨5.61%报5.65美元
市场透视 · 05-16
Alumis Inc.盘中异动 股价大涨5.61%报5.65美元
奥本海默:维持Alumis评级
证券之星 · 05-15
奥本海默:维持Alumis评级
奥本海默:维持Alumis(ALMS.US)评级,由优于大市调整至优于大市评级, 目标价由26.00美元调整至25.00美元。
金融界 · 05-15
奥本海默:维持Alumis(ALMS.US)评级,由优于大市调整至优于大市评级, 目标价由26.00美元调整至25.00美元。
加载更多
公司概况
公司名称:
Alumis Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Alumis Inc.于2021年1月29日注册成立,为特拉华州公司。他们是一家临床阶段的生物制药公司,最初专注于开发两种酪氨酸激酶2(TYK2)抑制剂:ESK-001,一种他们正在开发的第二代抑制剂,以实现最大的靶向抑制,以及A-005,一种中枢神经系统渗透分子。该公司的使命是通过靶向治疗取代广泛的免疫抑制,显著改善患者的生活。
发行价格:
--
{"stockData":{"symbol":"ALMS","market":"US","secType":"STK","nameCN":"Alumis Inc.","latestPrice":3.5,"timestamp":1752091200000,"preClose":3.48,"halted":0,"volume":522999,"delay":0,"floatShares":8664240,"shares":54405544,"eps":-8.309579,"marketStatus":"盘前交易","change":0.02,"latestTime":"07-10 07:30:32 EDT","open":3.51,"high":3.5887,"low":3.42,"amount":1833656.0938587,"amplitude":0.048477,"askPrice":3.57,"askSize":860,"bidPrice":3.14,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-8.309579,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752154200000},"marketStatusCode":1,"adr":0,"listingDate":1719547200000,"exchange":"NASDAQ","adjPreClose":3.5,"postHourTrading":{"tag":"盘后","latestPrice":3.5,"preClose":3.5,"latestTime":"19:37 EDT","volume":2426,"amount":8492.3684,"timestamp":1752104262432},"volumeRatio":0.7350397825329948,"impliedVol":1.3818,"impliedVolPercentile":0.2097},"requestUrl":"/m/hq/s/ALMS","defaultTab":"news","newsList":[{"id":"2549638528","title":"Alumis Inc.盘中异动 早盘快速上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549638528","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549638528?lang=zh_cn&edition=full","pubTime":"2025-07-08 21:41","pubTimestamp":1751982089,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日21时41分,Alumis Inc.股票出现波动,股价急速拉升5.14%。Alumis Inc.股票所在的生物技术行业中,整体涨幅为0.19%。其相关个股中,Prokidney Corp.、Rallybio Corporation、Humacyte, Inc.涨幅较大,Zyversa Therapeutics, Inc.、Plus Therapeutics, Inc.、Rallybio Corporation较为活跃,换手率分别为826.26%、134.99%、120.32%,振幅较大的相关个股有Rallybio Corporation、Prokidney Corp.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com,振幅分别为52.59%、41.20%、36.88%。Alumis Inc.公司简介:Alumis Inc 是一家处于临床阶段的生物制药公司,专注于识别、收购并加速开发和商业化用于自身免疫性疾病的变革性药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708214129953ae703&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708214129953ae703&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2548885094","title":"Alumis Inc.盘中异动 大幅上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548885094","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548885094?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:07","pubTimestamp":1751386040,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时07分,Alumis Inc.股票出现波动,股价急速拉升5.00%。Alumis Inc.股票所在的生物技术行业中,整体涨幅为1.20%。Alumis Inc.公司简介:Alumis Inc 是一家处于临床阶段的生物制药公司,专注于识别、收购并加速开发和商业化用于自身免疫性疾病的变革性药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702000720a4c952b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702000720a4c952b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2547013190","title":"Alumis Inc.盘中异动 股价大涨5.30%报3.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2547013190","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547013190?lang=zh_cn&edition=full","pubTime":"2025-06-30 22:59","pubTimestamp":1751295581,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日22时59分,Alumis Inc.股票出现异动,股价大幅上涨5.30%。截至发稿,该股报3.18美元/股,成交量22.4186万股,换手率0.22%,振幅5.22%。Alumis Inc.股票所在的生物技术行业中,整体涨幅为0.63%。Alumis Inc.公司简介:Alumis Inc 是一家处于临床阶段的生物制药公司,专注于识别、收购并加速开发和商业化用于自身免疫性疾病的变革性药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630225941953164e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630225941953164e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2546730743","title":"Alumis Inc.盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546730743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546730743?lang=zh_cn&edition=full","pubTime":"2025-06-27 00:06","pubTimestamp":1750953960,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日00时06分,Alumis Inc.股票出现异动,股价急速拉升5.12%。截至发稿,该股报3.08美元/股,成交量27.0453万股,换手率0.26%,振幅5.12%。Alumis Inc.股票所在的生物技术行业中,整体跌幅为0.03%。Alumis Inc.公司简介:Alumis Inc 是一家处于临床阶段的生物制药公司,专注于识别、收购并加速开发和商业化用于自身免疫性疾病的变革性药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627000600a71f2c7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627000600a71f2c7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2545623600","title":"Alumis Inc.盘中异动 早盘股价大涨5.00%报2.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545623600","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545623600?lang=zh_cn&edition=full","pubTime":"2025-06-24 22:21","pubTimestamp":1750774888,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日22时21分,Alumis Inc.股票出现异动,股价急速上涨5.00%。截至发稿,该股报2.94美元/股,成交量13.4177万股,换手率0.13%,振幅5.68%。Alumis Inc.股票所在的生物技术行业中,整体涨幅为0.76%。Alumis Inc.公司简介:Alumis Inc 是一家处于临床阶段的生物制药公司,专注于识别、收购并加速开发和商业化用于自身免疫性疾病的变革性药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506242221299529b567&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506242221299529b567&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2545290179","title":"Alumis Inc.盘中异动 临近午盘急速下挫5.32%报2.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545290179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545290179?lang=zh_cn&edition=full","pubTime":"2025-06-20 23:51","pubTimestamp":1750434689,"startTime":"0","endTime":"0","summary":"北京时间2025年06月20日23时51分,Alumis Inc.股票出现异动,股价快速下挫5.32%。截至发稿,该股报2.85美元/股,成交量42.4293万股,换手率0.41%,振幅7.97%。Alumis Inc.股票所在的生物技术行业中,整体跌幅为0.68%。Alumis Inc.公司简介:Alumis Inc 是一家处于临床阶段的生物制药公司,专注于识别、收购并加速开发和商业化用于自身免疫性疾病的变革性药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620235130a4b4f085&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620235130a4b4f085&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2542345695","title":"Guggenheim:重申Alumis(ALMS.US)买入评级, 目标价18.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542345695","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542345695?lang=zh_cn&edition=full","pubTime":"2025-06-10 23:01","pubTimestamp":1749567689,"startTime":"0","endTime":"0","summary":"Guggenheim:重申Alumis(ALMS.US)买入评级, 目标价18.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/10230150989222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ALMS"],"gpt_icon":0},{"id":"2542333187","title":"Alumis Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542333187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542333187?lang=zh_cn&edition=full","pubTime":"2025-06-09 22:11","pubTimestamp":1749478281,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日22时11分,Alumis Inc.股票出现异动,股价大幅跳水5.01%。截至发稿,该股报3.41美元/股,成交量10.342万股,换手率0.10%,振幅7.80%。Alumis Inc.股票所在的生物技术行业中,整体涨幅为0.34%。Alumis Inc.公司简介:Alumis Inc 是一家临床阶段的生物制药公司,专注于识别、收购和加速自身免疫性疾病变革性药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092211219514de86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092211219514de86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2540069749","title":"Alumis Inc.盘中异动 早盘快速上涨5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540069749","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540069749?lang=zh_cn&edition=full","pubTime":"2025-06-04 21:33","pubTimestamp":1749044015,"startTime":"0","endTime":"0","summary":"北京时间2025年06月04日21时33分,Alumis Inc.股票出现异动,股价大幅上涨5.88%。Alumis Inc.股票所在的生物技术行业中,整体涨幅为0.61%。其相关个股中,Cellectar Biosciences, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、再鼎医药涨幅较大,Nucana Plc、Conduit Pharmaceuticals Inc.、Cellectar Biosciences, Inc.较为活跃,换手率分别为518.46%、498.48%、267.37%,振幅较大的相关个股有Cellectar Biosciences, Inc.、知临集团、Processa Pharmaceuticals, Inc.,振幅分别为20.71%、15.46%、10.68%。Alumis Inc.公司简介:Alumis Inc 是一家临床阶段的生物制药公司,专注于识别、收购和加速自身免疫性疾病变革性药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604213336a499fc22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604213336a499fc22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2540790285","title":"Alumis Inc.盘中异动 急速跳水5.00%报3.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540790285","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540790285?lang=zh_cn&edition=full","pubTime":"2025-06-03 02:31","pubTimestamp":1748889100,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日02时31分,Alumis Inc.股票出现异动,股价大幅下挫5.00%。截至发稿,该股报3.33美元/股,成交量85.6082万股,换手率0.83%,振幅8.00%。Alumis Inc.股票所在的生物技术行业中,整体涨幅为1.46%。Alumis Inc.公司简介:Alumis Inc 是一家临床阶段的生物制药公司,专注于识别、收购和加速自身免疫性疾病变革性药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603023140a6f76803&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603023140a6f76803&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2539202922","title":"Alumis Inc.盘中异动 大幅下跌5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539202922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539202922?lang=zh_cn&edition=full","pubTime":"2025-05-30 21:31","pubTimestamp":1748611876,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日21时31分,Alumis Inc.股票出现波动,股价快速跳水5.88%。Alumis Inc.股票所在的生物技术行业中,整体跌幅为2.82%。其相关个股中,Bioline Rx Ltd、Klotho Neurosciences Inc C/Wts 21/06/2029 、Psyence Biomedical Ltd.涨幅较大,Bioline Rx Ltd、Nucana Plc、Psyence Biomedical Ltd.较为活跃,换手率分别为311.73%、130.99%、63.64%,振幅较大的相关个股有Bioline Rx Ltd、Imunon, Inc.、Psyence Biomedical Ltd.,振幅分别为15.83%、14.07%、10.73%。Alumis Inc.公司简介:Alumis Inc 是一家临床阶段的生物制药公司,专注于识别、收购和加速自身免疫性疾病变革性药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530213116976b3493&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530213116976b3493&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2538464980","title":"Alumis Inc.盘中异动 早盘大幅跳水5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538464980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538464980?lang=zh_cn&edition=full","pubTime":"2025-05-27 21:37","pubTimestamp":1748353027,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日21时37分,Alumis Inc.股票出现波动,股价急速下挫5.34%。截至发稿,该股报4.61美元/股,成交量2.1213万股,换手率0.02%,振幅5.54%。Alumis Inc.股票所在的生物技术行业中,整体涨幅为0.67%。Alumis Inc.公司简介:Alumis Inc 是一家临床阶段的生物制药公司,专注于识别、收购和加速自身免疫性疾病变革性药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527213707aa2c99da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527213707aa2c99da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2537992311","title":"Alumis Inc.2025财年第一财季实现净利润-98.96百万美元,同比减少98.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537992311","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537992311?lang=zh_cn&edition=full","pubTime":"2025-05-23 00:00","pubTimestamp":1747929642,"startTime":"0","endTime":"0","summary":"5月23日,Alumis Inc.公布财报,公告显示公司2025财年第一财季净利润为-98.96百万美元,同比减少98.52%;其中营业收入为17.39百万美元,每股基本收益为-1.82美元。从资产负债表来看,Alumis Inc.总负债92.98百万美元,其中短期债务2.55百万美元,资产负债比为0.03,流动比率为0.04。机构评级:截至2025年5月23日,当前有4家机构对Alumis Inc.目标价做出预测,其中目标均价为21.25美元,其中最低目标价为14.00美元,最高目标价为29.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000223a6e914da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000223a6e914da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALMS"],"gpt_icon":0},{"id":"2537894411","title":"Alumis Inc.盘中异动 早盘快速下挫7.95%报4.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537894411","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537894411?lang=zh_cn&edition=full","pubTime":"2025-05-22 21:30","pubTimestamp":1747920645,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日21时30分,Alumis Inc.股票出现异动,股价急速下跌7.95%。截至发稿,该股报4.40美元/股,成交量1.6541万股,换手率0.03%,振幅3.97%。Alumis Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Alumis Inc.公司简介:Alumis Inc 是一家临床阶段的生物制药公司,专注于识别、收购和加速自身免疫性疾病变革性药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522213045a6e8f0f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522213045a6e8f0f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2537366449","title":"Alumis Inc.盘中异动 快速上涨5.33%报5.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537366449","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537366449?lang=zh_cn&edition=full","pubTime":"2025-05-21 21:31","pubTimestamp":1747834313,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日21时31分,Alumis Inc.股票出现波动,股价急速拉升5.33%。截至发稿,该股报5.14美元/股,成交量3.6466万股,换手率0.07%,振幅4.02%。Alumis Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Alumis Inc.公司简介:Alumis Inc 是一家临床阶段的生物制药公司,专注于识别、收购和加速自身免疫性疾病变革性药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505212131539760d99e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505212131539760d99e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2536301643","title":"Alumis Inc.盘中异动 急速下挫5.38%报5.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536301643","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536301643?lang=zh_cn&edition=full","pubTime":"2025-05-20 21:32","pubTimestamp":1747747951,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日21时32分,Alumis Inc.股票出现波动,股价快速下挫5.38%。截至发稿,该股报5.63美元/股,成交量1.8957万股,换手率0.03%,振幅3.95%。Alumis Inc.股票所在的生物技术行业中,整体涨幅为0.15%。Alumis Inc.公司简介:Alumis Inc 是一家临床阶段的生物制药公司,专注于识别、收购和加速自身免疫性疾病变革性药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052021323194fcc4df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052021323194fcc4df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2536343216","title":"Alumis Inc.盘中异动 下午盘急速拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536343216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536343216?lang=zh_cn&edition=full","pubTime":"2025-05-20 02:01","pubTimestamp":1747677660,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日02时01分,Alumis Inc.股票出现波动,股价急速拉升5.03%。Alumis Inc.股票所在的生物技术行业中,整体涨幅为0.38%。其相关个股中,Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Protagenic Therapeutics, Inc.、Polyrizon Ltd.、Nucana Plc较为活跃,换手率分别为14093.36%、10438.63%、2723.08%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、Moolec Science Sa C/Wts ,振幅分别为862.26%、236.96%、60.00%。Alumis Inc.公司简介:Alumis Inc 是一家临床阶段的生物制药公司,专注于识别、收购和加速自身免疫性疾病变革性药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520020101a4845d04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520020101a4845d04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2536348054","title":"Alumis Inc.盘中异动 股价大涨5.61%报5.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536348054","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536348054?lang=zh_cn&edition=full","pubTime":"2025-05-17 00:21","pubTimestamp":1747412492,"startTime":"0","endTime":"0","summary":"北京时间2025年05月17日00时21分,Alumis Inc.股票出现异动,股价快速上涨5.61%。Alumis Inc.股票所在的生物技术行业中,整体涨幅为0.38%。Alumis Inc.公司简介:Alumis Inc 是一家临床阶段的生物制药公司,专注于识别、收购和加速自身免疫性疾病变革性药物的开发和商业化。消息层面,截至00时21分,《奥本海默:维持Alumis评级》资讯为影响Alumis Inc.的重要信息。该信息摘要如下:奥本海默:维持Alumis评级,由优于大市调整至优于大市评级,目标价由26.00美元调整至25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517002132a4811eda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517002132a4811eda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2535749708","title":"奥本海默:维持Alumis评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2535749708","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535749708?lang=zh_cn&edition=full","pubTime":"2025-05-16 02:21","pubTimestamp":1747333286,"startTime":"0","endTime":"0","summary":"奥本海默:维持Alumis(ALMS.US)评级,由优于大市调整至优于大市评级,目标价由26.00美元调整至25.00美元。Alumis(ALMS.US)公司简介:Alumis Inc是一家临床阶段的生物制药公司,专注于识别、收购和加速自身免疫性疾病变革性药物的开发和商业化。该公司利用其专有的精确数据分析平台、生物学见解、以及在精准医学药物发现、开发和免疫学方面拥有丰富经验的专家团队,通过用靶向疗法取代广泛的免疫抑制来创造显著改善患者生活的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516022512a6e0aaec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516022512a6e0aaec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALMS"],"gpt_icon":0},{"id":"2535872940","title":"奥本海默:维持Alumis(ALMS.US)评级,由优于大市调整至优于大市评级, 目标价由26.00美元调整至25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535872940","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535872940?lang=zh_cn&edition=full","pubTime":"2025-05-16 02:13","pubTimestamp":1747332785,"startTime":"0","endTime":"0","summary":"奥本海默:维持Alumis(ALMS.US)评级,由优于大市调整至优于大市评级, 目标价由26.00美元调整至25.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/16021350429926.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ALMS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alumis.com","stockEarnings":[{"period":"1week","weight":0.0671},{"period":"1month","weight":0.0204},{"period":"3month","weight":-0.4876},{"period":"6month","weight":-0.5},{"period":"1year","weight":-0.7021},{"period":"ytd","weight":-0.5547}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1896},{"period":"6month","weight":0.0751},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.0648}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Alumis Inc.于2021年1月29日注册成立,为特拉华州公司。他们是一家临床阶段的生物制药公司,最初专注于开发两种酪氨酸激酶2(TYK2)抑制剂:ESK-001,一种他们正在开发的第二代抑制剂,以实现最大的靶向抑制,以及A-005,一种中枢神经系统渗透分子。该公司的使命是通过靶向治疗取代广泛的免疫抑制,显著改善患者的生活。","exchange":"NASDAQ","name":"Alumis Inc.","nameEN":"Alumis Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alumis Inc.(ALMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Alumis Inc.(ALMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Alumis Inc.,ALMS,Alumis Inc.股票,Alumis Inc.股票老虎,Alumis Inc.股票老虎国际,Alumis Inc.行情,Alumis Inc.股票行情,Alumis Inc.股价,Alumis Inc.股市,Alumis Inc.股票价格,Alumis Inc.股票交易,Alumis Inc.股票购买,Alumis Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alumis Inc.(ALMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Alumis Inc.(ALMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}